Market Overview - U.S. stocks exhibited mixed performance, with the Nasdaq Composite increasing by over 100 points on Monday [1] - Cannabis-linked stocks experienced significant gains following President Trump's video promoting the health benefits of cannabis [1] Company Highlights - Tilray Brands, Inc. (NASDAQ: TLRY) saw a sharp increase in shares, rising 39.2% to $1.5983 [1] - Merus N.V. (NASDAQ: MRUS) gained 36.6% to $94.14 after Genmab agreed to acquire the company for $97 per share [4] - Better Home & Finance Holding Company (NASDAQ: BETR) increased by 20.1% to $63.60, supported by a $75 million at-the-market offering for Class A shares [4] - BTQ Technologies Corp. (NASDAQ: BTQ) jumped 20% to $6.36, as Danal began proof-of-concept for BTQ's quantum-secure Stablecoin settlement network [4] - SNDL Inc. (NASDAQ: SNDL) rose 18.8% to $2.77, benefiting from the positive sentiment around cannabis stocks [4] - Innoviz Technologies Ltd. (NASDAQ: INVZ) increased by 15.6% to $1.9701 after Goldman Sachs upgraded the stock from Neutral to Buy, raising the price target from $1.50 to $2.50 [4] - Sandisk Corporation (NASDAQ: SNDK) shares jumped 14.3% to $111.06 [4] - GDEV Inc. (NASDAQ: GDEV) rose 12.7% to $29.24 [4] - Ondas Holdings Inc. (NASDAQ: ONDS) gained 12.2% to $8.59 [4] - Pony AI Inc. (NASDAQ: PONY) increased by 10.3% to $23.36, with Citigroup initiating coverage with a Buy rating and a price target of $29 [4] - Galaxy Digital (NASDAQ: GLXY) gained 9.5% to $33.85 [4] - Western Digital Corporation (NASDAQ: WDC) rose 9% to $116.48 after Rosenblatt raised its price target from $90 to $125 while maintaining a Buy rating [4] - New Oriental Education & Technology Group Inc. (NYSE: EDU) increased by 5% to $53.85, with B of A Securities maintaining a Buy rating and raising the price target from $56.2 to $58.2 [4] - GLOBALFOUNDRIES Inc. (NASDAQ: GFS) rose 5% to $37.40 following a collaboration announcement with Corning for developing detachable fiber connector solutions [4]

Investors Riding the High Cannabis Stocks Following President Trump's Truth Social Post Investorideas.com (www.investorideas.com Newswire) a go-to platform for big investing ideas, including cannabis stocks reports on trading for cannabis stocks this morning following news that President Trump was advocating the potential benefits from the use of cannabidiol in senior healthcare in a post on Truth Social. https://truthsocial.com/@realDonaldTrump/posts/115283887618990920 Aurora Cannabis Inc. (TSX: A ...

President Donald Trump posted a video on Truth Social on Sunday, promoting the potential health benefits of cannabis. Cannabis stocks lit up on Monday after Trump resurrected hopes for a change in federal drug policy. TLRY stock is on fire. See the real-time price action here. Is Trump Pro-Cannabis? The video, created by The Commonwealth Project, suggested that CBD should be covered under Medicare, calling it “the most important senior health initiative of the century.”It also claimed that CBD could slow th ...

Group 1 - Alan Brochstein is a pioneer in the cannabis investment sector, having focused exclusively on this industry since 2007 [1] - He founded AB Analytical Services to provide independent consulting to registered investment advisors [1] - Brochstein is the managing partner of New Cannabis Ventures, which has been a key provider of financial information in the cannabis industry since 2015 [1] Group 2 - Alan has led the investing group 420 Investor since 2013, which focuses on publicly-traded cannabis stocks [2] - The group moved to Seeking Alpha in 2023 and covers 20 stocks, providing investment news, earnings report previews, and post-report analyses [2] - Features of the 420 Investor group include a model portfolio, 10 weekly videos with chart analysis, 3 weekly summary pieces, a monthly newsletter, and a chat for questions [2]

NEW YORK and LEAMINGTON, Ontario, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, today announced that the Company will release its financial results for the first quarter which ended August 31, 2025 before the financial markets open on Thursday, October 9, 2025. Live Conference Call and Audio Webcast Tilray will host a live ...

Core Insights - Tilray Brands (NASDAQ: TLRY) has experienced a significant stock price increase of nearly 200%, rising from $0.42 in early July to $1.24, primarily due to potential reclassification of cannabis by the Trump administration from Schedule I to Schedule III [2][15] - The company is focusing on product differentiation and expanding its operations in Europe, including launching new EU-GMP certified medical cannabis strains in Germany [3] - Investors are questioning whether TLRY stock remains a compelling investment at its current price, with significant upside potential linked to the prospective reclassification of marijuana [4][16] Financial Performance - Tilray's revenues have grown at an average rate of 9.9% over the last three years, with a 4.1% increase from $789 million to $821 million in the past 12 months [12] - The latest quarterly revenues decreased by 2.3% to $225 million from $230 million a year prior [12] - The company reported an operating income of -$108 million, resulting in an operating margin of -13.1% and a cash flow margin of -11.5%, generating nearly -$95 million in operating cash flow [12] - TLRY's net income for the corresponding period was approximately -$2.2 billion, indicating a net margin of around -266.3% [12] Debt and Financial Stability - TLRY's debt stood at $329 million at the end of the most recent quarter, with a current market cap of $1.2 billion, resulting in a debt-to-equity ratio of 26.7% [13] - The company's cash (including cash equivalents) constitutes $256 million of $2.1 billion in total assets, leading to a cash-to-assets ratio of 12.4% [13] Stock Performance - TLRY stock has plummeted 97.6% from a peak of $63.91 on February 10, 2021, to $1.52 on June 23, 2023, compared to a peak-to-trough decline of 25.4% for the S&P 500 [14] - The stock has not yet rebounded to its pre-crisis peak, with the highest value since then being $3.31 on September 11, 2023, and currently trading at $1.24 [14] - TLRY stock dropped 88.4% from a high of $21.36 on January 15, 2020, to $2.47 on March 18, 2020, versus a peak-to-trough decline of 33.9% for the S&P 500 [14] Market Position and Strategy - Tilray Brands engages in the research, cultivation, production, marketing, and distribution of medical cannabis products across various segments, including GMP-certified flowers, oils, vapes, edibles, and topicals [7] - The company is enhancing its business operations by concentrating on product differentiation and developing new products for its premium segment [3]

Group 1: Market Overview - The S&P 500 index has shown fluctuations, reflecting broader market trends and investor sentiment [1] - Recent performance of Kohl's Corp indicates challenges in retail, with a focus on adapting to changing consumer behaviors [1] - GoPro Inc continues to innovate in the action camera market, aiming to capture a larger share despite competitive pressures [1] Group 2: Company-Specific Insights - Kohl's Corp reported a decline in sales, prompting strategic reviews to enhance customer engagement and operational efficiency [1] - GoPro Inc's latest product launch has received positive feedback, suggesting potential for revenue growth in the upcoming quarters [1] - Tilray Inc is navigating regulatory changes in the cannabis industry, which may impact its market positioning and growth strategies [1]

Core Viewpoint - Tilray Brands, Inc. is launching a festive lineup of Oktoberfest-inspired craft beers, blending German tradition with local creativity to celebrate the fall season [1][12]. Product Offerings - Atwater Brewery's Bloktober Fest (ABV 6.1%): A German Style Marzen with bready, nut-like characters and a crisp hop finish [2]. - Blue Point Brewing Company's Oktoberfest (ABV 5.7%): A traditional German-style Marzen lager, particularly notable on the East Coast [4]. - Breckenridge Brewery's Oktoberfest (ABV 6%): An elegant German Amber Lager with bready, toasty aromas and a clean, dry finish [6]. - Terrapin Beer Company's Oktoberfest (ABV 5.5%): A Marzen-style lager brewed with 100% German malts and hops [8]. - Widmer Brothers Brewing's Okto Festive Ale (ABV 5.5%): A medium-bodied amber beer, ideal for autumn [10]. Company Overview - Tilray Brands, Inc. operates globally in the lifestyle and consumer packaged goods sector, focusing on cannabis, beverages, wellness, and entertainment [13]. - The company aims to be a leading premium lifestyle brand with over 40 brands in more than 20 countries [13].

Company Performance - Tilray Brands, Inc. (TLRY) stock decreased by 2.46% to $1.19, underperforming the S&P 500 which fell by 0.1% [1] - Over the past month, Tilray's shares appreciated by 15.09%, outperforming the Medical sector's gain of 0.86% and the S&P 500's gain of 2.57% [1] Earnings Expectations - Analysts expect Tilray to report earnings of -$0.03 per share, indicating a year-over-year growth of 25% [2] - The consensus estimate for revenue is $206.83 million, reflecting a 3.39% increase compared to the same quarter last year [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at -$0.11 per share, representing a change of -1200% from the prior year [3] - Revenue for the fiscal year is estimated at $877.28 million, indicating a growth of 6.81% from the previous year [3] Analyst Estimates and Rankings - Recent changes in analyst estimates for Tilray are important as they reflect short-term business trends and can indicate a favorable outlook on business health and profitability [4] - The Zacks Rank system, which evaluates estimate changes, currently ranks Tilray as 3 (Hold) [6] Industry Context - The Medical - Products industry, which includes Tilray, ranks in the top 36% of all industries according to the Zacks Industry Rank [7] - The top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Core Viewpoint - Tilray Brands stock has experienced a significant bullish rebound, increasing from a low of $0.352 in June to $1.25, representing a 256% rise [1] Company Summary - The stock price movement indicates strong market interest and potential investor confidence in Tilray Brands [1] - The increase in stock price suggests a positive sentiment surrounding the company's future prospects [1] Market Expectations - Market participants are closely monitoring developments as they anticipate further movements in Tilray Brands stock [1] - The current price level may indicate a pivotal point for future trading activity and investment decisions [1]